Oncotarget

Interview with Dr. Alexander Pohlman from Rush University Medical Center, Chicago, IL

Dr. Alexander Pohlman from Rush Medical College, Rush University Medical Center, Chicago, IL, describes a recent review published by Oncotarget that he co-authored entitled, "The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer."

DOI - https://doi.org/10.18632/oncotarget.28202

Full text - https://www.oncotarget.com/article/28202/text/

Correspondence to - Jeffrey A. Borgia - jeffrey_a_borgia@rush.edu

Keywords - IGF , lung cancer, biomarkers , screening, prognostication

Oncotarget Scientific Integrity Banner


Copyright © 2022 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC